WS #16115
Healthcare is emerging as a beneficiary of capital rotation out of high-multiple AI stocks. Piper Sandler maintained Overweight ratings and raised price targets for Regeneron Pharmaceuticals and BridgeBio Pharma, citing strong fundamentals. This sector rotation is supported by broader market caution on tech debt and geopolitical risks, making defensive healthcare names with clear pipelines attractive to institutional investors.
Healthcare Sector Rotation
Healthcare is emerging as a beneficiary of capital rotation out of high-multiple AI stocks. Piper Sandler maintained Overweight ratings and raised price targets for Regeneron Pharmaceuticals and BridgeBio Pharma, citing strong fundamentals. This sector rotation is supported by broader market caution on tech debt and geopolitical risks, making defensive healthcare names with clear pipelines attractive to institutional investors.